CLYM · Climb Bio, Inc.
$17.28
+0.26 (+1.53%)
At close · Aug 21
Market Cap
$992.50M
Shares
57.44M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$17.28
Open$17.26
Day$17.00–17.71
52W close$1.64–17.44
Avg vol 30d1.1M
Short int7.0M · 12.3% float · 6.8d
Short vol60%
Last earningsSep 3, 2026
DataAug 2021–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Sep 3, 2026
Scheduled
· in 2 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 15.1 · calm
Equity put/call 0.51
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+115%
above
Price vs 50-day avg
+30%
above
RSI (14)
74
overbought
MACD trend
Positive
52-week position
99%
near high
Momentum
relative strength
1-month return
+35%
trailing
6-month return
+144%
trailing
YTD return
+332%
this year
Relative strength
+133%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $13 › 200d $8 — 50d above 200d
Institutional flow
Accumulating
+35% holders QoQ · +51 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.25% of float · ▲ +2.4% MoM · 6.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
108 holders — near 3-yr high, broad support
Squeeze score
71
high risk · 0–100
Fundamentals
EPS growth
+42%
Y/Y
Free cash flow
$-54.5M
Balance sheet
$35.7M
net cash
Quant / Vol
risk profile
Volatility
96%
annualized · 1-yr
Max drawdown
−34%
past year
ATR
6.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+115%
Bullish
Price vs 50-day avg
+30%
Bullish
RSI (14)
74
Bearish
MACD trend
Positive
Bullish
52-week position
99%
Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $13 › 200d $8 — 50d above 200d
Institutional flow
Accumulating
+35% holders QoQ · +51 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
12.25% of float · ▲ +2.4% MoM · 6.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
108 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $2
Now $17 · 99%
Range high $17
vs 200-day avg +115%
vs 50-day avg +30%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CLYM
this stock
Climb Bio, Inc.
|
$992.50M | +332.0% | — | — | 12.3% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$138.91B | +20.9% | +46.2% | 31.9 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$85.87B | +8.1% | +20.8% | 20.7 | 3.3% |
|
ARGX
Argenx SE
|
$64.66B | +23.6% | — | — | 2.1% |
|
CSLLY
Csl Ltd
|
$57.97B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CLYM | +5.8% | +34.6% | +144.4% | +45.2% | +332.0% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | +7.2% | +31.0% | +132.9% | +42.7% | +319.7% |
Key facts
CIK
1768446
CUSIP
28658R106
13F (30d)
106 filings
106 filers
Visit website
Investor relations